Company: DVAX
Filing Date: 2025-04-07
Form Type: PREC14A
Source: 0001193125-25-074629
Chunk: 0

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-07
Form: PREC14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box:

| ☒ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 
 14a-6(e)(2))                                                       |

| ☐ | Definitive Proxy Statement |

| ☐ | Definitive Additional Materials |

| ☐ | Soliciting Material Under § 240.14a-12 |

Dynavax Technologies Corporation (Name of Registrant as Specified In Its Charter) DEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD DEEP TRACK CAPITAL, LP DAVID KROIN BRETT A. ERKMAN JEFFREY S. FARROW MICHAEL MULLETTE DONALD J. SANTEL (Name of Persons(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):

| ☒ | No fee required |

| ☐ | Fee paid previously with preliminary materials |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 
 14a-6(i)(1) and 0-11                                                           |

PRELIMINARY COPY SUBJECT TO COMPLETION DATED APRIL [● ], 2025 2025 ANNUAL MEETING OF STOCKHOLDERS OF DYNAVAX TECHNOLOGIES CORPORATION PROXY STATEMENT OF DEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD DEEP TRACK CAPITAL, LP DAVID KROIN BRETT A. ERKMAN JEFFREY S. FARROW MICHAEL MULLETTE DONALD J. SANTEL PLEASE FOLLOW THE INSTRUCTIONS SET FORTH ON THE ENCLOSED WHITE PROXY CARD TO VOTE VIA THE INTERNET OR BY TELEPHONE OR MARK SIGN, DATE AND RETURN THE ENCLOSED WHITE PROXY CARD BY MAIL TODAY This proxy statement (this “Proxy Statement”) and accompanying WHITEproxy card are being furnished to stockholders of Dynavax Technologies Corporation, a Delaware corporation (“Dynavax” or the “Company”), by Deep Track Biotechnology Master Fund, Ltd., a Cayman